Thol et al. [56] combined the expression data of MN1, ERG, BAALC, and EVI1 (MEBE) (associated with poor prognosis in patients with cytogenetically normal AML) to study their prognostic effects in MDS. Here, RUNX1 is linked to myelodysplastic syndrome.